Trials / Completed
CompletedNCT00346515
EPIC US Feasibility Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting
Evaluating the Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting: The EPIC US Feasibility Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (planned)
- Sponsor
- Lumen Biomedical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Multicenter, prospective, feasibility study designed to demonstrate the performance and safety of the Lumen Biomedical, Inc. FiberNet™ Embolic Protection System as an adjunctive device during carotid artery percutaneous intervention using the Guidant Acculink carotid stent in high surgical risk patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FiberNet Emboli Protection System |
Timeline
- Start date
- 2006-06-01
- Completion
- 2008-01-01
- First posted
- 2006-06-30
- Last updated
- 2008-10-21
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00346515. Inclusion in this directory is not an endorsement.